Authors

Sahin Y. Dilber S. Kelestimur F.

Institution

Dr. Y. I Sahin, Dept. Obstetrics and Gynecology, Faculty of Medicine, Erciyes University, 38039 Kayseri; Turkey.

Title:

Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism (2001-3246).

Source:

Fertility and Sterility. Vol 75(3) (pp96-500), 2001.

Abstract:

Objectives:

To compare the clinical efficacy and safety of the combination of Diane 35 (2 mg of cyproterone acetate, and 35 mug of ethinyl estradiol) plus finasteride (5 mg), and Diane 35 alone in the treatment of hirsutism.

Design:

Prospective randomized clinical study.

Setting:

Outpatients in Erciyes University Medical School.

Patients:

Forty women with hirsutism were selected. Intervention(s): For 1 year, group patients (n = 20) were treated with Diane 35 alone (2 mg of cyproterone acetate and 35 mug of ethinyl estradiol) daily on days 5 to 25 of the menstrual cycle and group patients (n = 20) with Diane 35 plus finasteride (5 mg daily).

Main Outcome Measure(s):

Hirsutism was graded at 6-month intervals using the Ferriman-Gallwey method. The basal hormone levels of total and free testosterone (T), androstenedione, DHEAS, and sex-hormone-binding globulin (SHBG) were measured by radioimmunoassay before the study. Total T, free T, SHBG, and DHEAS were also measured at 6-month intervals for 1 year. Multiscreen blood chemistry and side effects were evaluated during the treatment.

Results:

Thirty-four patients completed the 12-month study period. A significant decrease in the hirsutism score as compared to baseline was observed after 12 months with both Diane 35 treatment (mean +/- SD, 15.62 +/- 4.89 vs. 9.75 +/- 3.97) and Diane 35 plus finasteride treatment (16.27 +/- 6.90 vs. 8.38 +/- 4.44). The percentage decreases in the hirsutism score (mean percent +/- SD) were 30.26 +/- 14.56 vs. 34.70 +/- 11.60 at 6 months, 38.09 +/- 11.46 vs. 48.14 +/- 14.27 at 12 months in the Diane 35 and the Diane 35 plus finasteride groups, respectively. The percentage reduction in the hirsutism score in the Diane 35 plus finasteride group at 12 months was greater than in the Diane 35 group (P<.05).

Conclusion(s):

The percentage decrease in the hirsutism score at 12 months was higher in the Diane 35 plus finasteride group than in the Diane 35 group. We believe that Diane 35 plus finasteride is an effective and safe combination for the treatment of hirsutism. Copyright (copyright) 2001 American Society for Reproductive Medicine.





See Also:

Hirsutism

Alopecia

Do you have an unanswered women's health question?

Please let us have your general question on our NEW FORUM / MESSAGE BOARDS facility and we will try to answer it for you. I am sure that you will appreciate that we cannot offer advice on the management of an individual's specific problem.

Women's Health

Women's Health Forum

Thank you for choosing to visit us.

This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London.

I do hope that you find the answers to your questions in the patient information and medical advice provided. If you still have unanswered questions, please consider entering them into one of our forums and I will try to assist you.

 Women's Health